PL2536422T3 - Sposoby leczenia cukrzycowych owrzodzeń stóp - Google Patents

Sposoby leczenia cukrzycowych owrzodzeń stóp

Info

Publication number: PL2536422T3
Authority: PL; Poland
Prior art keywords: methods; diabetic foot; foot ulcers; treating diabetic; ulcers
Prior art date: 2011-02-02

Application number

PL12703408T

Other languages

English (en)

Inventor

Kathleen E Rodgers

Gere S Dizerega

Original Assignee

Univ Southern California

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2011-02-02

Filing date

2012-02-01

Publication date

2014-09-30

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=45571822&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL2536422(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2012-02-01 Application filed by Univ Southern California filed Critical Univ Southern California

2014-09-30 Publication of PL2536422T3 publication Critical patent/PL2536422T3/pl

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/08—Peptides having 5 to 11 amino acids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/08—Peptides having 5 to 11 amino acids
- A61K38/085—Angiotensins
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Chemical & Material Sciences (AREA)
Engineering & Computer Science (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Bioinformatics & Cheminformatics (AREA)
Chemical Kinetics & Catalysis (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Epidemiology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Gastroenterology & Hepatology (AREA)
Diabetes (AREA)
Immunology (AREA)
Vascular Medicine (AREA)
Dermatology (AREA)
Genetics & Genomics (AREA)
Obesity (AREA)
Emergency Medicine (AREA)
Hematology (AREA)
Biotechnology (AREA)
Endocrinology (AREA)
Molecular Biology (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Medicinal Preparation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Peptides Or Proteins (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

PL12703408T 2011-02-02 2012-02-01 Sposoby leczenia cukrzycowych owrzodzeń stóp PL2536422T3 (pl)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US201161438780P	2011-02-02	2011-02-02
EP12703408.0A EP2536422B8 (en)	2011-02-02	2012-02-01	Methods for treating diabetic foot ulcers
PCT/US2012/023484 WO2012106427A2 (en)	2011-02-02	2012-02-01	Methods for treating diabetic foot ulcers

Publications (1)

Publication Number	Publication Date
PL2536422T3 true PL2536422T3 (pl)	2014-09-30

Family

ID=45571822

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PL12703408T PL2536422T3 (pl)	2011-02-02	2012-02-01	Sposoby leczenia cukrzycowych owrzodzeń stóp

Country Status (20)

Country	Link
US (3)	US8207233B1 (pl)
EP (1)	EP2536422B8 (pl)
JP (2)	JP5469777B2 (pl)
KR (1)	KR101514414B1 (pl)
CN (1)	CN102858360B (pl)
AU (1)	AU2012212220B2 (pl)
BR (1)	BR112013019513A2 (pl)
CA (1)	CA2793515C (pl)
CL (1)	CL2012002560A1 (pl)
CO (1)	CO6592101A2 (pl)
DK (1)	DK2536422T3 (pl)
EA (1)	EA026440B1 (pl)
ES (1)	ES2479765T3 (pl)
MX (1)	MX2012010783A (pl)
PE (1)	PE20130379A1 (pl)
PL (1)	PL2536422T3 (pl)
PT (1)	PT2536422E (pl)
SG (1)	SG183960A1 (pl)
WO (1)	WO2012106427A2 (pl)
ZA (1)	ZA201207340B (pl)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EA026440B1 (ru) *	2011-02-02	2017-04-28	Университи Оф Сатерн Калифорния	Способ лечения диабетической язвы стопы
WO2013172956A1 (en)	2012-05-14	2013-11-21	University Of Southern California	Methods for limiting development of a skin wound
RU2015108678A (ru) *	2012-09-17	2016-11-10	Терикс Фармасьютикалз Лтд.	Составы ангиотензина для перорального применения
US9289500B2 (en) *	2013-02-22	2016-03-22	The Regents Of The University Of California	Saccharide-peptide hydrogels
EP2968441A1 (en)	2013-03-15	2016-01-20	University of Southern California	Methods for treating multiple sclerosis
EP2967049B1 (en)	2013-03-15	2020-09-02	University Of Southern California	Methods, compounds, and compositions for the treatment of angiotensin-related diseases
WO2015138288A1 (en) *	2014-03-10	2015-09-17	Rush University Medical Center	Methods of promotion of healing of diabetic wounds
WO2016108130A1 (en) *	2014-12-30	2016-07-07	Sun Pharmaceutical Industries Limited	Topical pharmaceutical compositions comprising nebivolol for the treatment of diabetic wounds
US20180344680A1 (en) *	2015-12-08	2018-12-06	The Arizona Board Of Regents On Behalf Of The University Of Arizona	Compositions and methods for treatment, amelioration, and prevention of diabetes-related skin ulcers
WO2021072225A1 (en) *	2019-10-09	2021-04-15	Rush University Medical Center	Modulating interleukin-10 signaling to boost healing in diabetic wounds

Family Cites Families (31)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5015629A (en)	1989-06-26	1991-05-14	University Of Southern California	Tissue repair
AU3062392A (en) *	1991-11-04	1993-06-07	Novo Nordisk A/S	Pdgf gel formulation
PT730465E (pt)	1993-09-24	2002-06-28	Univ Southern California	Utilizacao de angiotensina iii e de analogos desta em cicatrizacao de tecidos
US5955430A (en)	1993-09-24	1999-09-21	University Of Southern California	Use of angiotensin II fragments and analogs thereof in tissue repair
CA2172494A1 (en)	1993-09-24	1995-03-30	Kathleen Elizabeth Rodgers	Use of angiotensin ii analogs in tissue repair
US5834432A (en)	1995-06-06	1998-11-10	The University Of Southern California	Use of angiotensin II Type 2 receptor agonists in tissue repair
US6110895A (en)	1996-12-16	2000-08-29	University Of Southern California	Method of promoting healing in skin grafts
US6335195B1 (en)	1997-01-28	2002-01-01	Maret Corporation	Method for promoting hematopoietic and mesenchymal cell proliferation and differentiation
AU6650098A (en)	1997-02-04	1998-08-25	University Of Southern California	Method for accelerating healing of thermal injuries
US6248587B1 (en)	1997-11-26	2001-06-19	University Of Southern Cailfornia	Method for promoting mesenchymal stem and lineage-specific cell proliferation
US6165978A (en)	1997-12-12	2000-12-26	University Of Southern California	Wound healing composition
JP2002502858A (ja)	1998-02-09	2002-01-29	ユニヴァースティオブサザーンカリフォルニア	ケラチノサイト増殖促進法
US7173011B2 (en)	2000-11-20	2007-02-06	University Of Southern California	Radiation therapy methods
US6455500B1 (en)	1998-03-10	2002-09-24	University Of Southern California	Radiation therapy methods
US6498138B1 (en)	1998-03-11	2002-12-24	University Of Southern California	Method of promoting production of living tissue equivalents
US6762167B1 (en)	1998-05-11	2004-07-13	University Of Southern California	Methods for treating a patient undergoing chemotherapy
CA2322963C (en)	1998-05-11	2004-04-13	University Of Southern California	Methods to increase white blood cell survival after chemotherapy
US6916783B2 (en)	1998-07-13	2005-07-12	University Of Southern California	Methods for accelerating bone and cartilage growth and repair
EP1094829B8 (en)	1998-07-13	2004-09-22	University Of Southern California	Methods for accelerating bone and cartilage growth and repair
CA2339330A1 (en)	1998-08-13	2000-02-24	University Of Southern California	Methods to increase blood flow to ischemic tissue
US6730775B1 (en)	1999-03-23	2004-05-04	University Of Southern California	Methods for limiting scar and adhesion formation
US7338938B2 (en)	1999-05-10	2008-03-04	University Of Southern California	Methods for treating a patient undergoing chemotherapy
US6821953B1 (en)	1999-12-16	2004-11-23	University Of Southern California	Methods for treating and preventing damage to mucosal tissue
WO2001044270A2 (en)	1999-12-16	2001-06-21	University Of Southern California	Methods for treating and preventing diabetic complications by use of angiotensin-related peptides
AU2001218024A1 (en) *	2000-06-19	2002-01-02	University Of Southern California	Methods for treating and preventing alopecia
US20060058238A1 (en) *	2004-09-15	2006-03-16	Lee Laurent-Applegate	Fetal skin cell protein compositions for the treatment of skin conditions, disorders or diseases and methods of making and using the same
JP2011506446A (ja) *	2007-12-11	2011-03-03	コーダセラピューティクス，インコーポレイテッド	損傷した創傷治癒組成物および治療
WO2009114461A2 (en)	2008-03-10	2009-09-17	University Of Southern California	Angiotensin (1-7) dosage forms and uses thereof
WO2011120032A1 (en) *	2010-03-26	2011-09-29	University Of Southern California	Methods for treating combined radiation and thermal injury
WO2012021578A1 (en)	2010-08-10	2012-02-16	University Of Southern California	Use of angiotensin- ii (1-7) in cell trans planation and as an agent for preventing/treating norovirus infection
EA026440B1 (ru) *	2011-02-02	2017-04-28	Университи Оф Сатерн Калифорния	Способ лечения диабетической язвы стопы

2012
- 2012-02-01 EA EA201201296A patent/EA026440B1/ru not_active IP Right Cessation
- 2012-02-01 AU AU2012212220A patent/AU2012212220B2/en not_active Ceased
- 2012-02-01 WO PCT/US2012/023484 patent/WO2012106427A2/en not_active Ceased
- 2012-02-01 JP JP2013502927A patent/JP5469777B2/ja not_active Expired - Fee Related
- 2012-02-01 PL PL12703408T patent/PL2536422T3/pl unknown
- 2012-02-01 CA CA2793515A patent/CA2793515C/en active Active
- 2012-02-01 SG SG2012066452A patent/SG183960A1/en unknown
- 2012-02-01 CN CN201280001085.4A patent/CN102858360B/zh active Active
- 2012-02-01 BR BR112013019513A patent/BR112013019513A2/pt not_active Application Discontinuation
- 2012-02-01 US US13/364,061 patent/US8207233B1/en active Active
- 2012-02-01 KR KR1020127023804A patent/KR101514414B1/ko active Active
- 2012-02-01 EP EP12703408.0A patent/EP2536422B8/en active Active
- 2012-02-01 ES ES12703408.0T patent/ES2479765T3/es active Active
- 2012-02-01 DK DK12703408.0T patent/DK2536422T3/da active
- 2012-02-01 MX MX2012010783A patent/MX2012010783A/es active IP Right Grant
- 2012-02-01 PE PE2012001812A patent/PE20130379A1/es not_active Application Discontinuation
- 2012-02-01 PT PT127034080T patent/PT2536422E/pt unknown
- 2012-04-06 US US13/441,653 patent/US8207234B1/en active Active
- 2012-05-09 US US13/467,253 patent/US8536231B2/en not_active Expired - Fee Related
- 2012-09-10 CO CO12154938A patent/CO6592101A2/es unknown
- 2012-09-14 CL CL2012002560A patent/CL2012002560A1/es unknown
- 2012-10-01 ZA ZA2012/07340A patent/ZA201207340B/en unknown
2013
- 2013-12-19 JP JP2013262634A patent/JP2014080425A/ja active Pending

Also Published As

Publication number	Publication date
EA026440B1 (ru)	2017-04-28
PT2536422E (pt)	2014-07-18
BR112013019513A2 (pt)	2019-06-11
KR20120137365A (ko)	2012-12-20
AU2012212220A1 (en)	2012-10-18
ES2479765T3 (es)	2014-07-24
JP5469777B2 (ja)	2014-04-16
WO2012106427A2 (en)	2012-08-09
CA2793515C (en)	2015-05-12
CN102858360A (zh)	2013-01-02
HK1180213A1 (en)	2013-10-18
CA2793515A1 (en)	2012-08-09
EA201201296A1 (ru)	2013-02-28
EP2536422B8 (en)	2023-06-21
MX2012010783A (es)	2012-11-23
EP2536422A2 (en)	2012-12-26
US8536231B2 (en)	2013-09-17
US20120329729A1 (en)	2012-12-27
ZA201207340B (en)	2013-02-27
CO6592101A2 (es)	2013-01-02
US8207234B1 (en)	2012-06-26
JP2014080425A (ja)	2014-05-08
KR101514414B1 (ko)	2015-05-04
DK2536422T3 (da)	2014-07-28
US8207233B1 (en)	2012-06-26
CN102858360B (zh)	2017-07-25
CL2012002560A1 (es)	2013-03-22
JP2013523781A (ja)	2013-06-17
WO2012106427A3 (en)	2012-09-20
AU2012212220B2 (en)	2013-04-04
EP2536422B1 (en)	2014-04-30
PE20130379A1 (es)	2013-04-13
SG183960A1 (en)	2012-10-30

Publication	Publication Date	Title
ZA201207340B (en)	2013-02-27	Methods for treating diabetic foot ulcers
PL2526141T3 (pl)	2017-12-29	Sposób obróbki powierzchniowej
ZA201208219B (en)	2013-07-31	Method for treating wasterwater
IL225623A0 (en)	2013-06-27	Psoriasis treatment methods
GB2483750B (en)	2013-05-15	Anti-slip step treatment
IL260077A (en)	2018-07-31	Methods of treating excess bilirubin in the blood with stanoporfin
EP2662092A4 (en)	2014-06-11	METHOD FOR SELECTING PATIENTS FOR THE ADMINISTRATION OF MEDICAMENTS FOR THE TREATMENT OF SEPSIS
GB201108797D0 (en)	2011-07-06	Surface treatment method
ZA201308117B (en)	2014-12-23	Avian-based treatment
GB201121950D0 (en)	2012-02-01	Treatment process
GB201105523D0 (en)	2011-05-18	Treatment method
EP2695540A4 (en)	2014-11-05	UPPER MATERIAL STRUCTURE FOR SHOES
GB201102283D0 (en)	2011-03-23	Treatment
GB201108301D0 (en)	2011-06-29	IVlg treatment for patients with Myeloma
GB201100455D0 (en)	2011-02-23	Methods relating to treatment
IL215567A0 (en)	2011-11-30	Process for surface treatment
GB201105056D0 (en)	2011-05-11	Treatment process
GB201119181D0 (en)	2011-12-21	Light treatment method
GB201118869D0 (en)	2011-12-14	Light treatment method
GB201119184D0 (en)	2011-12-21	Light treatment method
EP2768536A4 (en)	2015-07-15	METHOD OF TREATING TYPE I AND TYPE II DIABETES
GB201102268D0 (en)	2011-03-23	Treatment
GB201111247D0 (en)	2011-08-17	Treatment
GB201102272D0 (en)	2011-03-23	Treatment
GB201102274D0 (en)	2011-03-23	Treatment